Literature DB >> 9324130

Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis.

D Hsiang1, H Friess, M W Büchler, M Ebert, J Butler, M Korc.   

Abstract

BACKGROUND: Human pancreatic cancers exhibit a high frequency of K-ras mutations.
METHODS: In this study we used oligonucleotide specific hybridization to compare the frequency of K-ras mutations in genomic DNA samples prepared from 21 normal pancreatic tissues, 26 chronic pancreatitis tissues, and 24 pancreatic cancers.
RESULTS: None of the DNA samples from normal or chronic pancreatitis tissues exhibited a K-ras mutation at codons 12 or 13 of K-ras. In contrast, 17 of 24 DNA pancreatic cancers harbored a K-ras mutation. Validity of the methodology was confirmed by genotyping 7 human pancreatic cancer cell lines. Analysis of focal areas of proliferation from 5 chronic pancreatitis and 5 pancreatic cancer samples processed by selective ultraviolet radiation fractionation (SURF), a procedure used to enrich DNA isolation from foci of proliferating cells, revealed complete concordance with total genomic DNA analysis.
CONCLUSIONS: These findings indicate that the pancreatic parenchyma in patients with chronic pancreatitis most frequently does not possess a K-ras mutation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324130     DOI: 10.1016/s0002-9610(97)00133-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

2.  Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Beata Smolarz; Hanna Romanowicz-Makowska; Janusz Strzelczyk; Adam Janiak; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  K-ras and Dpc4 mutations in chronic pancreatitis: case series.

Authors:  Marijana Popović Hadzija; Marina Korolija; Jasminka Jakić Razumović; Pajica Pavković; Mirko Hadzija; Sanja Kapitanović
Journal:  Croat Med J       Date:  2007-04       Impact factor: 1.351

Review 4.  K-Ras mutations and benign pancreatic disease.

Authors:  M Löhr; P Maisonneuve; A B Lowenfels
Journal:  Int J Pancreatol       Date:  2000-04

5.  Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer.

Authors:  Louise J Barber; Juan M Rosa Rosa; Iwanka Kozarewa; Kerry Fenwick; Ioannis Assiotis; Costas Mitsopoulos; David Sims; Jarle Hakas; Marketa Zvelebil; Christopher J Lord; Alan Ashworth
Journal:  PLoS One       Date:  2011-07-05       Impact factor: 3.240

6.  Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.

Authors:  Guo-Xiong Zhou; Jie-Fei Huang; Zhao-Shen Li; Guo-Ming Xu; Feng Liu; Hong Zhang
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 7.  Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer.

Authors:  Craig D Logsdon; Baoan Ji
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

8.  Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis.

Authors:  Robert W Cowan; Erica D Pratt; Jin Muk Kang; Jun Zhao; Joshua J Wilhelm; Muhamad Abdulla; Edmund M Qiao; Luke P Brennan; Peter J Ulintz; Melena D Bellin; Andrew D Rhim
Journal:  Clin Transl Gastroenterol       Date:  2021-11-18       Impact factor: 4.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.